Published in Int J Biochem Mol Biol on May 18, 2012
Selective inhibitors of nuclear export (SINE)--a novel class of anti-cancer agents. J Hematol Oncol (2014) 1.11
XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). J Hematol Oncol (2014) 0.99
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell (2015) 0.97
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study. PLoS One (2014) 0.96
NESmapper: accurate prediction of leucine-rich nuclear export signals using activity-based profiles. PLoS Comput Biol (2014) 0.96
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma. Cancer Chemother Pharmacol (2014) 0.91
Aiding and abetting cancer: mRNA export and the nuclear pore. Trends Cell Biol (2013) 0.88
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget (2015) 0.88
Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes. J Virol (2015) 0.86
The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations. Scientifica (Cairo) (2012) 0.85
Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells. Cancer Biol Ther (2015) 0.80
Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer. J Ovarian Res (2015) 0.79
Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev (2015) 0.79
Allosteric control of the exportin CRM1 unraveled by crystal structure analysis. FEBS J (2014) 0.78
Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death. Oncotarget (2016) 0.77
Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65. Med Microbiol Immunol (2012) 0.77
Characterization of export receptor exportins (XPOs) in the parasite Schistosoma mansoni. Parasitol Res (2013) 0.76
A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus. CNS Neurosci Ther (2016) 0.76
Expression of chromosomal regional maintenance protein-1 may be associated with subcellular survivin expression in human gastric and colorectal carcinoma. Oncol Lett (2016) 0.75
CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells. Korean J Physiol Pharmacol (2016) 0.75
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines. BMC Vet Res (2014) 0.75
A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds. Oncotarget (2016) 0.75
XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells. J Cell Physiol (2016) 0.75
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget (2016) 0.75
Chromosome region maintenance 1 expression and its association with clinical pathological features in primary carcinoma of the liver. Exp Ther Med (2016) 0.75
Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene (2016) 0.75
CRM1 Inhibitors for Antiviral Therapy. Front Microbiol (2017) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
CRM1 is an export receptor for leucine-rich nuclear export signals. Cell (1997) 18.60
Wnt signaling and cancer. Genes Dev (2000) 18.53
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med (2005) 12.18
Linking colorectal cancer to Wnt signaling. Cell (2000) 11.58
Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem (1998) 10.74
CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature (1997) 10.49
Exportin 1 (Crm1p) is an essential nuclear export factor. Cell (1997) 10.32
The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell (1995) 9.98
Identification of a signal for rapid export of proteins from the nucleus. Cell (1995) 9.92
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet (1995) 9.06
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell (1996) 8.77
Nucleocytoplasmic transport. Science (1996) 8.76
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell (1996) 7.69
Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature (1997) 7.47
Protein import into nuclei: association and dissociation reactions involving transport substrate, transport factors, and nucleoporins. Cell (1995) 6.97
Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A (1999) 6.81
Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell (1997) 6.28
BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer (2004) 6.24
Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer (2008) 5.65
Identification of different roles for RanGDP and RanGTP in nuclear protein import. EMBO J (1996) 5.53
The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J (1999) 5.44
The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus. EMBO J (1997) 5.08
The HIV-1 Rev protein. Annu Rev Microbiol (1998) 4.78
A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J (1999) 4.68
The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J (1997) 4.65
The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol (1997) 4.35
Identification of a major polypeptide of the nuclear pore complex. J Cell Biol (1982) 4.30
Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J Biol Chem (1994) 4.28
The RCC1 protein, a regulator for the onset of chromosome condensation locates in the nucleus and binds to DNA. J Cell Biol (1989) 4.13
Pores for thought: nuclear pore complex proteins. Trends Cell Biol (1994) 4.08
Dominant-negative mutants of importin-beta block multiple pathways of import and export through the nuclear pore complex. EMBO J (1997) 4.06
Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol (1998) 3.99
A cap-binding protein complex mediating U snRNA export. Nature (1995) 3.89
Structural biology of nucleocytoplasmic transport. Annu Rev Biochem (2007) 3.66
Characterization of proteins that interact with the cell-cycle regulatory protein Ran/TC4. Nature (1993) 3.66
Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol (2000) 3.65
Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol (2001) 3.63
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med (1997) 3.57
A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science (2001) 3.35
Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1. EMBO J (1995) 3.27
Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1. Genes Dev (1998) 3.27
The nuclear pore complex. Annu Rev Biochem (1995) 3.20
PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res (2005) 3.15
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol (2000) 3.14
Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci (2003) 2.97
Chromosomal passengers: the four-dimensional regulation of mitotic events. Chromosoma (2004) 2.94
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol (2000) 2.85
The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J Biol Chem (1998) 2.78
Nuclear export signals and the fast track to the cytoplasm. Cell (1995) 2.77
From nucleoporins to nuclear pore complexes. Curr Opin Cell Biol (1997) 2.75
Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol (2005) 2.73
The nuclear pore complex and nuclear transport. Cold Spring Harb Perspect Biol (2010) 2.71
Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure. EMBO J (1998) 2.71
Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature (2009) 2.56
Higher order chromosome structure is affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-kD protein preferentially localized in the nucleus and its periphery. J Cell Biol (1989) 2.48
BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol (2004) 2.46
p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J (2001) 2.45
Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol (2011) 2.43
Karyopherins and kissing cousins. Trends Cell Biol (1998) 2.42
The role of exportin-t in selective nuclear export of mature tRNAs. EMBO J (1998) 2.40
An integral membrane protein of the pore membrane domain of the nuclear envelope contains a nucleoporin-like region. J Cell Biol (1993) 2.32
The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol (2006) 2.19
Survivin and IAP proteins in cell-death mechanisms. Biochem J (2010) 2.18
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol (2005) 2.15
Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem (2002) 2.12
NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1. Nat Struct Mol Biol (2010) 2.12
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol (1994) 2.11
C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol (2001) 2.09
CRM1-mediated recycling of snurportin 1 to the cytoplasm. J Cell Biol (1999) 2.08
Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP. Science (2009) 2.08
Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem (1997) 2.05
The conserved transmembrane nucleoporin NDC1 is required for nuclear pore complex assembly in vertebrate cells. Mol Cell (2006) 2.04
Two-way trafficking with Ran. Trends Cell Biol (1998) 2.04
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res (1997) 2.00
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J (2002) 1.99
The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood (1996) 1.98
A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A (1994) 1.95
Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP. Mol Biol Cell (2006) 1.94
The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep (2002) 1.93
BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A (1998) 1.81
Flexible gates: dynamic topologies and functions for FG nucleoporins in nucleocytoplasmic transport. Eukaryot Cell (2009) 1.81
Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol Cell (2000) 1.77
p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res (2010) 1.74
CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Mol Biol Cell (2003) 1.72
Fission yeast pap1-dependent transcription is negatively regulated by an essential nuclear protein, crm1. Mol Cell Biol (1992) 1.68
Ran and nuclear transport. J Biol Chem (1998) 1.67
NDC1: a crucial membrane-integral nucleoporin of metazoan nuclear pore complexes. J Cell Biol (2006) 1.67
Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A (2000) 1.67
The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene (1996) 1.65
Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol (2011) 1.62
The case for Survivin as mitotic regulator. Curr Opin Cell Biol (2006) 1.59
Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A (2002) 1.57
Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer (2005) 1.52
Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ (2002) 1.50
Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358. EMBO J (2004) 1.44
CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res (2002) 1.44
BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J Biol Chem (2002) 1.43
Aberrant regulation of survivin by the RB/E2F family of proteins. J Biol Chem (2004) 1.58
Survivin splice variants regulate the balance between proliferation and cell death. Oncogene (2005) 1.46
Essential role for survivin in early brain development. J Neurosci (2005) 1.44
Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol Cancer (2005) 1.26
Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling. Aging Cell (2012) 1.22
Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. J Biol Chem (2010) 1.16
XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer. Mol Cancer Ther (2014) 1.13
Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure. Blood (2007) 1.07
Liver transplant for relapsed undifferentiated embryonal sarcoma in a young child. J Pediatr Surg (2009) 1.02
Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes (2008) 0.99
Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer. J Biol Chem (2012) 0.96
Survivin: an inhibitor of apoptosis in pediatric cancer. Pediatr Blood Cancer (2006) 0.93
EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells. BMC Mol Biol (2010) 0.90
Poor outcome in a pediatric patient with acute myeloid leukemia associated with a variant t(8;21) and trisomy 6. Cancer Genet Cytogenet (2009) 0.87
Survivin and Granzyme B-induced apoptosis, a novel anticancer therapy. Mol Cancer Ther (2006) 0.85
Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells. J Biol Chem (2009) 0.85
Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood (2006) 0.82
Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia. Am J Hematol (2004) 0.78
A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia. Pediatrics (2010) 0.78
Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Hum Pathol (2011) 0.78
Targeting survivin's co-conspirators: do alternative methods of trapping survivin in the nucleus have potential in triple-negative breast cancer therapy? Future Oncol (2012) 0.77
Rapamycin induces the anti-apoptotic protein survivin in neuroblastoma. Int J Biochem Mol Biol (2012) 0.76